Cargando…
A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey
BACKGROUND: Buprenorphine–naloxone (BUP) initiation in emergency departments improves follow-up and survival among patients with opioid use disorder. We aimed to assess self-reported BUP-related practices and attitudes among emergency physicians. METHODS: We designed a cross-sectional physician surv...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476213/ https://www.ncbi.nlm.nih.gov/pubmed/34548331 http://dx.doi.org/10.9778/cmajo.20200190 |
_version_ | 1784575560184233984 |
---|---|
author | Kestler, Andrew Kaczorowski, Janusz Dong, Kathryn Orkin, Aaron M. Daoust, Raoul Moe, Jessica Van Pelt, Kelsey Andolfatto, Gary Klaiman, Michelle Yan, Justin Koh, Justin J. Crowder, Kathryn Webster, Devon Atkinson, Paul Savage, David Stempien, James Besserer, Floyd Wale, Jason Lam, Alice Scheueremeyer, Frank |
author_facet | Kestler, Andrew Kaczorowski, Janusz Dong, Kathryn Orkin, Aaron M. Daoust, Raoul Moe, Jessica Van Pelt, Kelsey Andolfatto, Gary Klaiman, Michelle Yan, Justin Koh, Justin J. Crowder, Kathryn Webster, Devon Atkinson, Paul Savage, David Stempien, James Besserer, Floyd Wale, Jason Lam, Alice Scheueremeyer, Frank |
author_sort | Kestler, Andrew |
collection | PubMed |
description | BACKGROUND: Buprenorphine–naloxone (BUP) initiation in emergency departments improves follow-up and survival among patients with opioid use disorder. We aimed to assess self-reported BUP-related practices and attitudes among emergency physicians. METHODS: We designed a cross-sectional physician survey by adapting a validated questionnaire on opioid harm reduction practices, attitudes and barriers. We recruited physician leads from 6 Canadian provinces to administer surveys to the staff physicians in their emergency department groups between December 2018 and November 2019. We included academic and community non-locum emergency department staff physicians. We excluded responses from emergency department groups with response rates less than 50% to minimize nonresponse bias. Primary (BUP prescribing practices) and secondary (willingness and attitudes) outcomes were analyzed using descriptive statistics. RESULTS: After excluding 1 group for low response (9/26 physicians), 652 of 798 (81.7%) physicians responded from 22 groups serving 34 emergency departments. Among respondents, 64.1% (95% confidence interval [CI] 60.4%–67.8%, emergency department group range 7.1%–100.0%) had prescribed BUP at least once in their career, 38.4% had prescribed it for home initiation and 24.8% prescribed it at least once a month. Overall, 68.9% (95% CI 65.3%–72.4%, emergency department group range 24.1%–97.6%) were willing to administer BUP, 64.2% felt it was a major responsibility and 37.1% felt they understood people who use drugs. Respondents most frequently rated lack of adequate training (58.2%) and lack of time (55.2%) as very important barriers to BUP initiation. INTERPRETATION: Two-thirds of the emergency physicians surveyed prescribed BUP, although only one-quarter did so regularly and one-third prescribed it for home initiation; wide variation between emergency department groups existed. Strategies to increase BUP initiation must address physicians’ lack of time and training for BUP initiation and improve their understanding of people who use drugs. |
format | Online Article Text |
id | pubmed-8476213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | CMA Joule Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84762132021-10-01 A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey Kestler, Andrew Kaczorowski, Janusz Dong, Kathryn Orkin, Aaron M. Daoust, Raoul Moe, Jessica Van Pelt, Kelsey Andolfatto, Gary Klaiman, Michelle Yan, Justin Koh, Justin J. Crowder, Kathryn Webster, Devon Atkinson, Paul Savage, David Stempien, James Besserer, Floyd Wale, Jason Lam, Alice Scheueremeyer, Frank CMAJ Open Research BACKGROUND: Buprenorphine–naloxone (BUP) initiation in emergency departments improves follow-up and survival among patients with opioid use disorder. We aimed to assess self-reported BUP-related practices and attitudes among emergency physicians. METHODS: We designed a cross-sectional physician survey by adapting a validated questionnaire on opioid harm reduction practices, attitudes and barriers. We recruited physician leads from 6 Canadian provinces to administer surveys to the staff physicians in their emergency department groups between December 2018 and November 2019. We included academic and community non-locum emergency department staff physicians. We excluded responses from emergency department groups with response rates less than 50% to minimize nonresponse bias. Primary (BUP prescribing practices) and secondary (willingness and attitudes) outcomes were analyzed using descriptive statistics. RESULTS: After excluding 1 group for low response (9/26 physicians), 652 of 798 (81.7%) physicians responded from 22 groups serving 34 emergency departments. Among respondents, 64.1% (95% confidence interval [CI] 60.4%–67.8%, emergency department group range 7.1%–100.0%) had prescribed BUP at least once in their career, 38.4% had prescribed it for home initiation and 24.8% prescribed it at least once a month. Overall, 68.9% (95% CI 65.3%–72.4%, emergency department group range 24.1%–97.6%) were willing to administer BUP, 64.2% felt it was a major responsibility and 37.1% felt they understood people who use drugs. Respondents most frequently rated lack of adequate training (58.2%) and lack of time (55.2%) as very important barriers to BUP initiation. INTERPRETATION: Two-thirds of the emergency physicians surveyed prescribed BUP, although only one-quarter did so regularly and one-third prescribed it for home initiation; wide variation between emergency department groups existed. Strategies to increase BUP initiation must address physicians’ lack of time and training for BUP initiation and improve their understanding of people who use drugs. CMA Joule Inc. 2021-09-21 /pmc/articles/PMC8476213/ /pubmed/34548331 http://dx.doi.org/10.9778/cmajo.20200190 Text en © 2021 CMA Joule Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Research Kestler, Andrew Kaczorowski, Janusz Dong, Kathryn Orkin, Aaron M. Daoust, Raoul Moe, Jessica Van Pelt, Kelsey Andolfatto, Gary Klaiman, Michelle Yan, Justin Koh, Justin J. Crowder, Kathryn Webster, Devon Atkinson, Paul Savage, David Stempien, James Besserer, Floyd Wale, Jason Lam, Alice Scheueremeyer, Frank A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey |
title | A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey |
title_full | A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey |
title_fullStr | A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey |
title_full_unstemmed | A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey |
title_short | A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey |
title_sort | cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 canadian emergency physician groups: a cross-sectional survey |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476213/ https://www.ncbi.nlm.nih.gov/pubmed/34548331 http://dx.doi.org/10.9778/cmajo.20200190 |
work_keys_str_mv | AT kestlerandrew acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT kaczorowskijanusz acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT dongkathryn acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT orkinaaronm acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT daoustraoul acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT moejessica acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT vanpeltkelsey acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT andolfattogary acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT klaimanmichelle acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT yanjustin acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT kohjustinj acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT crowderkathryn acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT websterdevon acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT atkinsonpaul acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT savagedavid acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT stempienjames acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT bessererfloyd acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT walejason acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT lamalice acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT scheueremeyerfrank acrosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT kestlerandrew crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT kaczorowskijanusz crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT dongkathryn crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT orkinaaronm crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT daoustraoul crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT moejessica crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT vanpeltkelsey crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT andolfattogary crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT klaimanmichelle crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT yanjustin crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT kohjustinj crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT crowderkathryn crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT websterdevon crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT atkinsonpaul crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT savagedavid crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT stempienjames crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT bessererfloyd crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT walejason crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT lamalice crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey AT scheueremeyerfrank crosssectionalsurveyonbuprenorphinenaloxonepracticeandattitudesin22canadianemergencyphysiciangroupsacrosssectionalsurvey |